RE:RE:Pretty disappointing if you ask me.I think that the PRC Partners analysis was not very helpful.
Sure, I can understand that without actual numbers it's not possible to calculate a proper valuation.But when one don't know, one can always make assumptions and be transparent. The statement of a 10-bagger is not backed up at all. I think it's much more than 10 if the expected anti-aging/anti-wrinkle deal comes true in 2023, but that's another story.
Despite the obvious well-connected writer, it does not support PRC Partners as a serious player.
Nor does the reference to their so called Swedish office give any serious impression. The address combined with the telephone number leads to a beauty salon owner in a mall outside Stockholm!
The part that makes me most nervous though is the reference to institutions and funds that Sirona are in talk with based on the Abbvie deal - will that lead to further dilution or not? That's must be communicated to the market as soon as possible, especially as they obviously have not bought shares on the open market - yet.
The best part of the analysis is that we are informed about the recruitment of a new CEO. The upcoming news release should give the share price a boost and combined with the AbbVie deal turn the page to a new chapter of the company.